白化病合并复发性视网膜脱离一例

2018-01-28 佚名 中华眼科杂志

患者男性,38岁,

【一般资料】

患者男性,38岁,

【主诉】

因左眼鼻侧黑影遮挡2d,2013年8月22日于天津医科大学眼科医院入院。

【既往史】

患者既往双眼高度近视眼,屈光度数为-13.00D,双眼先天性眼球震颤。

【家族史】

患者父母非近亲结婚,家族无其他患白化病者,患者父母及弟弟妹妹、独子均未有类似表现。

【体格检查】

入院时检查发现毛发色淡,余无异常。眉毛和睫毛有少许白色。眼部检查:右眼视力0.1,矫正0.12,眼压14.6mmHg(1mmHg=0.133kPa),眼球钟摆性震颤,前节(-),眼底可见视盘界清色可,视网膜呈豹纹状,后极部RPE无色素,透见粗大的脉络膜血管。左眼视力眼前手动,矫正不提高,眼压9.4mmHg,眼球钟摆性震颤,前节(-),眼底可见4~6点钟方位视网膜波浪形隆起,累及黄斑区,1点钟方位可见一马蹄形裂孔,大小约3/4PD,后极部RPE无色素,透见粗大的脉络膜血管(图1)。



【辅助检查】

B超示左眼视网膜脱离,OCT示左眼黄斑颞侧神经上皮层脱离。

【初步诊断

左眼孔源性视网膜脱离,双眼白化病眼底改变,双眼先天性眼球震颤,双眼高度近视,双眼高度近视性视网膜病变。

【治疗】

2013年8月23日局部麻醉下行左眼玻璃体切除术+气液交换+视网膜光凝+硅油填充术。术后眼部检查:左眼视力0.1,+5.00D矫正至1.2,眼压12.9mmHg,玻璃体腔硅油填充,眼底可见后极部RPE无色素,透见粗大的脉络膜血管,裂孔闭合,网膜在位(图2)。2014年3月10日局部麻醉下行左眼硅油取出术。术后眼部情况:左眼视力0.02,眼压13.7mmHg,视网膜在位。后患者视力逐渐下降,检查发现晶状体混浊,视网膜在位。2015年3月20日局部麻醉下行左眼白内障超声乳化联合人工晶状体植人术。2016年1月3日患者再次就诊,主因左眼鼻侧黑影遮挡2d入院。眼部检查:左眼视力0.08,眼压13mmHg,前节(-),眼底上方10点至2点视网膜隆起,上方赤道部变性带上可见裂孔(图3)。B超示左眼视网膜脱离。局部麻醉下行左眼玻璃体切除+视网膜光凝+C3F8填充术。术后1周左眼视力眼前手动,眼压10mmHg,玻璃体腔气体填充约占1/2。术后23d再次复诊,患者主诉左眼固定暗影遮挡。眼部检查:左眼视力0.04,眼压13mmHg,眼底可见下方4-8点钟方位视网膜隆起,累及黄斑。B超示左眼玻璃体腔内点状强回声,前部少量杂乱强回声,下方强回声膜状光带后连球壁。局部麻醉下行左眼玻璃体切除+硅油填充术。术后查体:左眼视力0.1,眼压20mmHg,玻璃体腔硅油填充,眼底网膜复位。




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1239929, encodeId=fe5512399298d, content=<a href='/topic/show?id=f5dee166210' target=_blank style='color:#2F92EE;'>#白化病#</a><a href='/topic/show?id=da21908054f' target=_blank style='color:#2F92EE;'>#视网膜脱离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71662, encryptionId=f5dee166210, topicName=白化病), TopicDto(id=90805, encryptionId=da21908054f, topicName=视网膜脱离)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 20 08:50:32 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909695, encodeId=c785190969511, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Nov 20 14:12:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298483, encodeId=8dd1298483b8, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 22 06:07:45 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270006, encodeId=9e2e12e00060a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Jan 30 02:12:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282878, encodeId=f9132828e8b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun Jan 28 13:55:23 CST 2018, time=2018-01-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1239929, encodeId=fe5512399298d, content=<a href='/topic/show?id=f5dee166210' target=_blank style='color:#2F92EE;'>#白化病#</a><a href='/topic/show?id=da21908054f' target=_blank style='color:#2F92EE;'>#视网膜脱离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71662, encryptionId=f5dee166210, topicName=白化病), TopicDto(id=90805, encryptionId=da21908054f, topicName=视网膜脱离)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 20 08:50:32 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909695, encodeId=c785190969511, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Nov 20 14:12:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298483, encodeId=8dd1298483b8, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 22 06:07:45 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270006, encodeId=9e2e12e00060a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Jan 30 02:12:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282878, encodeId=f9132828e8b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun Jan 28 13:55:23 CST 2018, time=2018-01-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1239929, encodeId=fe5512399298d, content=<a href='/topic/show?id=f5dee166210' target=_blank style='color:#2F92EE;'>#白化病#</a><a href='/topic/show?id=da21908054f' target=_blank style='color:#2F92EE;'>#视网膜脱离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71662, encryptionId=f5dee166210, topicName=白化病), TopicDto(id=90805, encryptionId=da21908054f, topicName=视网膜脱离)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 20 08:50:32 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909695, encodeId=c785190969511, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Nov 20 14:12:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298483, encodeId=8dd1298483b8, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 22 06:07:45 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270006, encodeId=9e2e12e00060a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Jan 30 02:12:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282878, encodeId=f9132828e8b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun Jan 28 13:55:23 CST 2018, time=2018-01-28, status=1, ipAttribution=)]
    2018-03-22 1e145228m78(暂无匿称)

    学习了.谢谢作者分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1239929, encodeId=fe5512399298d, content=<a href='/topic/show?id=f5dee166210' target=_blank style='color:#2F92EE;'>#白化病#</a><a href='/topic/show?id=da21908054f' target=_blank style='color:#2F92EE;'>#视网膜脱离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71662, encryptionId=f5dee166210, topicName=白化病), TopicDto(id=90805, encryptionId=da21908054f, topicName=视网膜脱离)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 20 08:50:32 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909695, encodeId=c785190969511, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Nov 20 14:12:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298483, encodeId=8dd1298483b8, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 22 06:07:45 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270006, encodeId=9e2e12e00060a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Jan 30 02:12:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282878, encodeId=f9132828e8b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun Jan 28 13:55:23 CST 2018, time=2018-01-28, status=1, ipAttribution=)]
    2018-01-30 zutt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1239929, encodeId=fe5512399298d, content=<a href='/topic/show?id=f5dee166210' target=_blank style='color:#2F92EE;'>#白化病#</a><a href='/topic/show?id=da21908054f' target=_blank style='color:#2F92EE;'>#视网膜脱离#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71662, encryptionId=f5dee166210, topicName=白化病), TopicDto(id=90805, encryptionId=da21908054f, topicName=视网膜脱离)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 20 08:50:32 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1909695, encodeId=c785190969511, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Nov 20 14:12:00 CST 2018, time=2018-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=298483, encodeId=8dd1298483b8, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Thu Mar 22 06:07:45 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1270006, encodeId=9e2e12e00060a, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Tue Jan 30 02:12:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282878, encodeId=f9132828e8b3, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun Jan 28 13:55:23 CST 2018, time=2018-01-28, status=1, ipAttribution=)]
    2018-01-28 changjiu

    学习一下谢谢

    0

相关资讯

Ophthalmology:术前姿势会影响视网膜脱离患者病情进展!

传统上,卧床休息和固定体位为黄斑上视网膜脱离(RD)的患者规定的术前姿势,以防止RD进展和中央凹脱离。执行这种建议可能会比较麻烦并且会很昂贵。本研究旨在调查术前姿势是否影响RD的进展。

Sci Rep:机器学习技术可以利用超宽域眼底图像诊断视网膜脱离!

日本Tsukazaki医院眼科系的Ohsugi H近日在Sci Rep杂志发表了一篇文章,题目为"Accuracy of deep learning, a machine-learning technology, using ultra-wide-field fundus ophthalmoscopy for detecting rhegmatogenous retinal detachment"

Am J Ophthalmol Case Rep:视网膜脱离和眼内压升高相关性的蛋白质组学分析!

爱荷华大学眼科实验室的Velez G近日在 Am J Ophthalmol Case Rep杂志发表了一篇文章,题目为"Proteomic Analysis of Elevated Intraocular Pressure with Retinal Detachment" ,他们报道了一例眼压升高与视网膜脱离的病例。